Insider Trading activities of Generex Biotechnology Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Generex Biotechnology Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Generex Biotechnology Corp since year 2005. Table 2 shows the detailed insider transactions of Generex Biotechnology Corp since 2005. The reporting company's ticker symbol is GNBT. The reporting company's CIK number is 1059784.
The total value of stock buying since 2005 is $313,597.
The total value of stock sales since 2005 is $441,523.
The total value of stock option exercises since 2005 is $367,958.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Generex Biotechnology Corp (GNBT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 10,000 $5,100 0 $0 0 $0
2016-02 0 $0 0 $0 14,890,033 $14,890
2015-04 0 $0 0 $0 5,874,162 $5,874
2014-10 0 $0 0 $0 542,154 $540
2013-06 0 $0 2,524,164 $88,345 2,524,164 $2,524
2012-07 0 $0 0 $0 508,197 $508
2012-06 0 $0 546,448 $50,273 546,448 $546
2011-05 0 $0 60,000 $13,450 0 $0
2011-04 20,000 $4,780 0 $0 0 $0
2011-01 0 $0 0 $0 576,752 $576
2010-10 54,000 $18,900 0 $0 0 $0
2009-11 30,000 $14,900 50,000 $25,000 0 $0
2009-10 0 $0 2,700 $1,862 0 $0
2009-01 12,359 $4,016 0 $0 0 $0
2008-10 40,000 $13,950 0 $0 0 $0
2008-04 0 $0 228,342 $262,593 300,000 $272,500
2008-03 2,700 $2,862 0 $0 0 $0
2008-02 0 $0 0 $0 70,000 $70,000
2006-03 29,100 $93,609 0 $0 0 $0
2006-02 70,000 $154,700 0 $0 0 $0
2005-08 1,000 $780 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Generex Biotechnology Corp insiders (GNBT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-16 Gluskin Anna E (CEO & Pres.) Buy 10,000 .51 5,100
2016-02-09 Fletcher Mark (President & CEO) Option Ex 14,890,033 .00 14,890
2015-04-27 Barratt John P Option Ex 5,874,162 .00 5,874
2014-10-06 Mcgee Brian (Director) Option Ex 35,714 .00 35
2014-10-06 Barratt John P (Director) Option Ex 35,714 .00 35
2014-10-06 Fletcher Mark (President & CEO) Option Ex 470,726 .00 470
2013-06-18 Fellows Stephen (Chief Financial Officer) Sale 2,524,164 .04 88,345
2013-06-06 Fellows Stephen (Chief Financial Officer) Option Ex 2,524,164 .00 2,524
2012-07-03 Masterson Nola E (Director) Option Ex 508,197 .00 508
2012-06-25 Fellows Stephen (Acting Chief Financial Officer) Sale 546,448 .09 50,273
2012-06-21 Fellows Stephen (Acting Chief Financial Officer) Option Ex 546,448 .00 546
2011-05-09 Perri Rose C (Director) Sale 15,000 .23 3,450
2011-05-06 Perri Rose C (Director) Sale 20,000 .22 4,500
2011-05-03 Perri Rose C (Director) Sale 25,000 .22 5,500
2011-04-06 Fletcher Mark (See Remarks) Buy 20,000 .24 4,780
2011-01-03 Perri Rose C (COO, CFO& Treas.) Option Ex 576,752 .00 576
2010-10-27 Perri Rose C (COO, CFO& Treas.) Buy 54,000 .35 18,900
2009-11-16 Perri Rose C (COO, CFO, Treas. & Secy.) Buy 10,000 .51 5,100
2009-11-13 Masterson Nola E (Director) Buy 10,000 .49 4,900
2009-11-13 Fletcher Mark (EVP & General Counsel) Buy 10,000 .49 4,900
2009-11-12 Masterson Nola E (Director) Sale 50,000 .50 25,000
2009-10-19 Masterson Nola E (Director) Sale 2,700 .69 1,862
2009-01-12 Fletcher Mark (EVP & General Counsel) Buy 12,359 .32 4,016
2008-10-31 Fletcher Mark (EVP & General Counsel) Buy 25,000 .38 9,375
2008-10-13 Perri Rose C (COO, CFO, Treas. & Secy.) Buy 15,000 .30 4,575
2008-04-18 Fletcher Mark (VP & General Counsel) Sale 228,342 1.15 262,593
2008-04-18 Fletcher Mark (VP & General Counsel) Option Ex 250,000 .89 222,500
2008-04-08 Bernstein Gerald (VP, Medical Affairs) Option Ex 50,000 1.00 50,000
2008-03-11 Masterson Nola E (Director) Buy 2,700 1.06 2,862
2008-02-27 Barratt John P (Director) Option Ex 70,000 1.00 70,000
2006-03-27 Mcgee Brian (Director) Buy 26,000 3.22 83,720
2006-03-20 Allport Settle Mindy J (Director) Buy 3,100 3.19 9,889
2006-02-28 Mcgee Brian (Director) Buy 70,000 2.21 154,700
2005-08-05 Amanatides Peter (Director) Buy 1,000 .78 780

Insider trading activities including stock purchases, stock sales, and option exercises of GNBT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Generex Biotechnology Corp (symbol GNBT, CIK number 1059784) see the Securities and Exchange Commission (SEC) website.